Warfarin Sodium IP/BP/USP - API

Name: Warfarin Sodium IP/BP/USP - API
Brand: GANDHI CHEMICALS
Price: 22.50 INR
Availability: InStock

Price 22.50 INR/ Gram

Get a Price/Quote

MOQ : 50 Kilograms

Warfarin Sodium IP/BP/USP - API Specification

Usage
Used as an anticoagulant (blood thinner) in pharmaceutical formulations Helps prevent and treat blood clots in veins and arteries Used in treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) Reduces risk of stroke and heart attack in patients with heart conditions Ideal for use in cardiovascular medicines and pharma research

CAS No
129-06-6

HS Code
291229

Appearance
White

Physical Form
Powder

Molecular Formula
C19H15NaO4

Purity
99.5%

Warfarin Sodium IP/BP/USP - API Trade Information

Minimum Order Quantity
50 Kilograms

Payment Terms
Cash Advance (CA), Cash in Advance (CID), Cheque

Supply Ability
1000 Kilograms Per Week

Delivery Time
Days

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Drum Packing

Main Export Market(s)
Asia

Main Domestic Market
All India

About Warfarin Sodium IP/BP/USP - API

Warfarin Sodium High-Quality Anticoagulant API

We offer premium-grade Warfarin Sodium, widely used as an anticoagulant in pharmaceutical formulations. Known for its high purity, stability, and precise composition, it is ideal for bulk drug manufacturing and research use.

Features:

High purity, pharma-grade quality
Complies with international standards
Safe, moisture-proof packaging

Applications:
Used in anticoagulant medicines and pharma intermediates.

Warfarin Sodium supplier, manufacturer, exporter, anticoagulant API, Warfarin Sodium powder, bulk drug raw material.

Extensive Applications in Cardiovascular Treatment

Warfarin Sodium IP/BP/USP is a frontline anticoagulant API, vital in the management and prevention of thromboembolic disorders. Its usage in treating conditions such as DVT, PE, and in minimizing stroke and heart attack risk underscores its importance in cardiovascular healthcare. This API's effectiveness makes it indispensable in pharmaceutical manufacturing and research.

Consistent Quality and High Purity

With a purity of 99.5%, Warfarin Sodium IP/BP/USP ensures reliable results in formulations. Its physical form as a white powder and standard compliance (IP/BP/USP) make it suitable for a variety of pharmaceutical and scientific applications. Quality assurance is maintained throughout the supply chain, reinforcing safety and performance in medication development.

FAQ's of Warfarin Sodium IP/BP/USP - API:

Q: How is Warfarin Sodium IP/BP/USP typically used in pharmaceutical formulations?

A: Warfarin Sodium is used as an active pharmaceutical ingredient in the formulation of anticoagulant medications designed to prevent and treat blood clots in veins and arteries, particularly for cardiovascular therapies and research.

Q: What are the primary medical conditions treated with Warfarin Sodium?

A: This API is essential in treating Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), as well as reducing the risk of stroke and heart attack in patients with underlying heart conditions.

Q: When should Warfarin Sodium-based medications be considered for use?

A: Warfarin Sodium-based medications are administered when a patient is at risk of developing blood clots, such as after certain surgeries, in chronic heart conditions, or in patients with a history of thromboembolic events.

Q: Where is Warfarin Sodium IP/BP/USP distributed and supplied?

A: This API is available through distributors, suppliers, importers, and traders, particularly across India, for use by pharmaceutical manufacturers and research institutions.

Q: What is the process of incorporating Warfarin Sodium API into medicines?

A: Pharmaceutical manufacturers blend Warfarin Sodium with other excipients during formulation to ensure accurate dosing and effective delivery in oral anticoagulant medication forms.

Q: What are the benefits of using Warfarin Sodium for anticoagulant therapy?

A: Warfarin Sodium reduces the formation of dangerous blood clots, helping to prevent complications like strokes, heart attacks, and pulmonary embolisms in at-risk individuals, thus improving patient outcomes.

Tell us about your requirement